Terguride

DB13399ExperimentalSmall molecule

Terguride: Overview.

Mechanism: Pharmacologically active on 5-hydroxytryptamine receptor 2B, 5-hydroxytryptamine receptor 2A, and Dopamine receptor D2
Curator reviewed
Formula / weight: C₂₀H₂₈N₄O · 340.471 g/mol (avg)

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyJOAHPSVPXZTVEP-YXJHDRRASA-NSMILES[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CN2C)NC(=O)N(CC)CC

Targets

What you can answer from here — as of July 07, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

698Drug interactionsStructured to mechanism, not free text

1ATC codeIncluding every combination product, plus 18 drug categories

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with Terguride, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.